Literature DB >> 22200858

Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells.

Jie Li1, Junfeng Yang, Peng Zhao, Shen Li, Renyun Zhang, Xiaobin Zhang, Dan Liu, Benshu Zhang.   

Abstract

The key pathological feature of Parkinson's disease (PD) is selective degeneration of the neuromelanin (NM)-pigmented dopaminergic neurons in the substantia nigra (SN). NM, like other risk factors, such as oxidative stress (OS) and α-synuclein (α-syn), is involved in the pathogenesis of PD. But whether or not NM synergizes with α-syn or OS in the pathogenesis of PD remains unexplored. In the present study, we examined the effects of NM on cellular viability, apoptosis and free radical production in α-syn over-expressing human neuroblastoma cell line (SK-N-SH) in the presence or absence of the oxidizer Fenton's Reagent (FR). We showed that NM synergized with FR in suppressing cell viability, and in inducing apoptosis and hydroxyl radical production in all SK-N-SH cell lines. α-Syn over-expressing cells exhibited more pronounced effect, especially the A53T mutation. Our findings suggest that NM synergizes with both OS and α-syn in conferring dopaminergic vulnerability, adding to our understanding of the pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200858     DOI: 10.1007/s00702-011-0753-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

1.  Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine.

Authors:  N G Kholodilov; T F Oo; R E Burke
Journal:  Neurosci Lett       Date:  1999-11-12       Impact factor: 3.046

Review 2.  From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.

Authors:  M Goedert; M G Spillantini; L C Serpell; J Berriman; M J Smith; R Jakes; R A Crowther
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-02-28       Impact factor: 6.237

3.  Pigments in the red nucleus and substantia nigra in man and in representative old and new world monkeys.

Authors:  R C Schwyn; J S King; C A Fox
Journal:  Bol Estud Med Biol       Date:  1970-01

4.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

5.  Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Authors:  K L Double; L Zecca; P Costi; M Mauer; C Griesinger; S Ito; D Ben-Shachar; G Bringmann; R G Fariello; P Riederer; M Gerlach
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

Review 6.  Modulation of alpha-synuclein aggregation by dopamine: a review.

Authors:  Su Ling Leong; Roberto Cappai; Kevin Jeffrey Barnham; Chi Le Lan Pham
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

7.  Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.

Authors:  Marco Bisaglia; Elisa Greggio; Dragan Maric; David W Miller; Mark R Cookson; Luigi Bubacco
Journal:  BMC Neurosci       Date:  2010-03-25       Impact factor: 3.288

8.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

9.  Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Authors:  A Kastner; E C Hirsch; O Lejeune; F Javoy-Agid; O Rascol; Y Agid
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

Review 10.  The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour.

Authors:  L Zecca; F A Zucca; P Costi; D Tampellini; A Gatti; M Gerlach; P Riederer; R G Fariello; S Ito; M Gallorini; D Sulzer
Journal:  J Neural Transm Suppl       Date:  2003
View more
  7 in total

Review 1.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 2.  Melanin affinity and its possible role in neurodegeneration.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist
Journal:  J Neural Transm (Vienna)       Date:  2013-07-03       Impact factor: 3.575

Review 3.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

4.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

5.  The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

Authors:  Tianhong Pan; Julie Zhu; Wen-Jen Hwu; Joseph Jankovic
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 6.  Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Authors:  Franziska Hopfner; Markus A Hobert; Corina Maetzler; Clint Hansen; Minh Hoang Pham; Caroline Moreau; Daniela Berg; David Devos; Walter Maetzler
Journal:  Front Neurol       Date:  2019-08-08       Impact factor: 4.003

7.  Assessment of Neuroprotective Effects of Low-Intensity Transcranial Ultrasound Stimulation in a Parkinson's Disease Rat Model by Fractional Anisotropy and Relaxation Time T2 Value.

Authors:  Yanchao Dong; Defeng Liu; Yuemei Zhao; Yi Yuan; Wenxi Wang; Shuo Wu; Xin Liang; Zhanqiu Wang; Lanxiang Liu
Journal:  Front Neurosci       Date:  2021-02-09       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.